Progress & Freedom Foundation FDA reform conference planned for Oct. 26.
This article was originally published in The Gray Sheet
Executive SummaryPROGRESS & FREEDOM FOUNDATION PLANNING OCTOBER FDA REFORM CONFERENCE to coincide with the release of a report being drafted by PFF staff on the European approval system and potential U.S. regulatory reforms. The report will be made available to participants prior to the conference, scheduled for Oct. 26 in Washington, D.C.
You may also be interested in...ï»¿
The Mallorca-based biotech is building a strong data package for SNF472 which the company believes will be an effective treatment for a number of calcification disorders in dialysis patients.
India’s Sun Pharma has been denied leave to appeal against a US court decision rejecting the company’s bid for dismissal of a multi-district antitrust lawsuit.
Former Sandoz executive Hector Armando Kellum has admitted involvement in a US generic price-fixing conspiracy, the US Department of Justice has announced.